Roche to launch SARS-CoV-2 rapid antigen test
The test can typically identify SARS-CoV-2 infection within 15 minutes
Read More
Tag: antigen
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
